BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of the gelatin plasma substitute, Haemaccel]. 1980

T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007430 Intraoperative Care Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests. Care, Intraoperative
D008297 Male Males
D011097 Polygeline A 3.5 per cent colloidal solution containing urea-cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander. Gelofusine,Haemaccel,Thomaegelin,Gelofusines,Haemaccels,Polygelines,Thomaegelins
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D006555 Hernia, Ventral A hernia caused by weakness of the anterior ABDOMINAL WALL due to midline defects, previous incisions, or increased intra-abdominal pressure. Ventral hernias include UMBILICAL HERNIA, incisional, epigastric, and spigelian hernias. Ventral Hernia,Hernias, Ventral,Ventral Hernias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
[Clinical experimentation with a new plasma substitute "Haemaccel"].
October 1968, Hospital (Rio de Janeiro, Brazil),
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
[HAEMACCEL, A NEW PLASMA SUBSTITUTE].
July 1964, Ugeskrift for laeger,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
[Use of Haemaccel, new plasma substitute in the treatment of shock].
July 1972, Revista espanola de anestesiologia y reanimacion,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
Gelatin as a plasma substitute.
July 1947, Surgery, gynecology & obstetrics,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
Haemaccel as a vitreous substitute.
January 1969, Bibliotheca haematologica,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
Succinylated gelatin as a plasma substitute.
January 1969, Bibliotheca haematologica,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
[Dissolved gelatin as a plasma substitute. 10 years of clinical use].
November 1975, Minerva anestesiologica,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
[Succinate-polymerized gelatin as a plasma substitute].
May 1968, Nihon rinsho. Japanese journal of clinical medicine,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
Modified fluid gelatin as a plasma substitute.
January 1978, Progress in clinical and biological research,
T Orłowski, and A Badowski, and J Lapiński, and W Witczak, and E Stanowski
Experiments with haemaccel as a vitreous substitute.
October 1966, Experimental eye research,
Copied contents to your clipboard!